NIKITA ENGINEER: Open Payments
NPI 1164064762 · PEARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,274 in 146 payments from 15 companies in 2025. Trend: 2023 $3,714 · 2024 $3,168 · 2025 $3,274
Food & beverage: $3,267Education: $8
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 12 | $369 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $366 |
| Neurocrine BioSciences, Inc. | 9 | $347 |
| Vanda Pharmaceuticals Inc. | 11 | $318 |
| Otsuka America Pharmaceutical, Inc. | 13 | $285 |
| Teva Pharmaceuticals USA, Inc. | 14 | $266 |
| ABBVIE INC. | 20 | $234 |
| E.R. Squibb & Sons, L.L.C. | 15 | $224 |
| Supernus Pharmaceuticals, Inc. | 13 | $197 |
| Janssen Pharmaceuticals, Inc | 2 | $157 |
Products named: Auvelity, CAPLYTA, INGREZZA, FANAPT, VRAYLAR, COBENFY, REXULTI, Qelbree.
Industry payments across TX — which companies pay providers there.
